Why Choose GenomeMe?

Wholesale Prices
Stringent Quality
Control Processes

Our Mission

To advance precision diagnostics through quality IHC antibodies.

Who We Are

GenomeMe Lab Inc. is a Vancouver-based biotech company specializing in mouse and rabbit IHC (immunohistochemistry) monoclonal antibodies for clinical diagnostic use. Since our inception in 2017, our goal has been to develop each of the 260+ clinical IHC antibodies in-house, making us the first and only institution to date to achieve this. We are on track to reach this R&D goal by the end of 2021 - hitting a monumental milestone in the history of our company’s development.

Because we develop and manufacture all of our antibodies in-house, we are able to offer our distributors, OEM partners, and valuable end user customers the best value and quality. GenomeMe Lab Inc. is rising to be a dominant player in diagnostic IHC applications, an increasingly essential part of future precision medicine technologies.


ISO 13485:2016
Products manufactured under Quality Management System conforming with ISO 13485:2016 as certified by Intertek.
Our products are CE IVD Certified for diagnostic use.
External quality assessments by NordiQC, an international profiency testing program for diagnostic IHC.


13th Biggest Life Sciences Company, 2019


qPCR is the gold standard in diagnostics, providing rapid, specific, and sensitive detection.
Next Generation Sequencing
We combine hybridoma and Next Generation Sequencing technologies to successfully develop mouse and rabbit monoclonal antibodies for clinical applications.
Our immunohistochemistry staining and Microtome equipment enable us to rapidly screen, validate, and QC our molecular pathology portfolio.